A detailed history of Arvest Investments, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Arvest Investments, Inc. holds 20,646 shares of NVS stock, worth $2.23 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
20,646
Previous 24,254 14.88%
Holding current value
$2.23 Million
Previous $2.45 Billion 18.45%
% of portfolio
0.32%
Previous 0.4%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$95.27 - $108.47 $343,734 - $391,359
-3,608 Reduced 14.88%
20,646 $2 Billion
Q4 2023

Jan 24, 2024

BUY
$92.27 - $101.54 $2.24 Million - $2.46 Million
24,254 New
24,254 $2.45 Billion

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $233B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Arvest Investments, Inc. Portfolio

Follow Arvest Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arvest Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Arvest Investments, Inc. with notifications on news.